U.S. market Open. Closes in 6 hours 6 minutes

STAA | STAAR Surgical Company Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 26.17 - 26.34
52 Week Range 25.88 - 52.68
Beta 0.64
Implied Volatility 56.56%
IV Rank 33.67%
Day's Volume 10,368
Average Volume 737,864
Shares Outstanding 49,275,900
Market Cap 1,294,477,893
Sector Healthcare
Industry Medical - Instruments & Supplies
IPO Date 1992-02-24
Valuation
Profitability
Growth
Health
P/E Ratio 59.70
Forward P/E Ratio N/A
EPS 0.44
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 1,056
Country USA
Website STAA
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
STAA's peers: BNGO, MBOT, RMD, WST, ICUI, MMSI, BDX, COO, HOLX, RGEN, HAE, NVST, ANGO, ATR
*Chart delayed
Analyzing fundamentals for STAA we got that it has average fundamentals where Valuation is considered to be overvalued, Profitability is very poor, Growth is exceptionally good and Health is very strong. For more detailed analysis please see STAA Fundamentals page.

Watching at STAA technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on STAA Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙